Evidence map›Paper›PMID 28874407›Full record

ArticleJournal of bacteriology2017

Anaerobic Mycobacterium tuberculosis Cell Death Stems from Intracellular Acidification Mitigated by the DosR Regulon.

Matthew J Reichlen, Rachel L Leistikow, Micah S Scobey, Sarah E M Born, Martin I Voskuil

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Microbiology spectrum · 2026
    Article
  2. Article
  3. Article
  4. The DosR regulon ofFrontiers in cellular and infection microbiology · 2025
    Article
  5. Article
  6. Review
  7. Phenotypic adaptation ofFrontiers in cellular and infection microbiology · 2022
    Review
  8. AC2P20 selectively killsRSC advances · 2021
    Article
  9. Metabolic Switching ofJournal of bacteriology · 2020
    Article
  10. Review
  11. Chemical disarming of isoniazid resistance inProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Matthew J ReichlenDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Rachel L LeistikowDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Micah S ScobeyDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Sarah E M BornDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Martin I VoskuilDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA martin.voskuil@ucdenver.edu.
University of Colorado Denver · US

Funding

The Mycobacterium Tuberculosis Dormancy ProgramR01AI061505 · NIAID · UNIVERSITY OF COLORADO DENVER · PI VOSKUIL, MARTIN INUA · 2005 to 2015
$3.6M
Molecular Pathogenesis of Infectious DiseasesT32AI052066 · NIAID · UNIVERSITY OF COLORADO DENVER · PI VAN DYK, LINDA F. · 2002 to 2022
$2.3M
NIAID NIH HHS R01 AI061505NIAID NIH HHS T32 AI052066
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adenosine TriphosphateAnti-Bacterial AgentsBacillusBacteria, AnaerobicBacterial ProteinsCell DeathCell RespirationElectron TransportHomeostasisHydrogen-Ion ConcentrationMycobacterium tuberculosisOxygenRegulonAdenosine TriphosphateAnti-Bacterial AgentsBacterial ProteinsOxygenanaerobicdormancyDosRhypoxiaMycobacterium tuberculosispH homeostasis

Identifiers

PMID28874407
PMCPMC5686587
OpenAlexW2753848467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.